Strides Pharma Science Limited announced earnings results for the first quarter ended June 30, 2021. For the first quarter, the company announced total revenue was INR 7,018.98 million compared to INR 7,941.02 million a year ago. Net loss was INR 2,052 million compared to net income of INR 1,035.64 million a year ago. Basic loss per share was INR 22.88 compared to basic earnings per share of INR 11.56 a year ago.